Rationale and design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

Παρόμοια τεκμήρια

• Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease
  ανά: Green, J, κ.ά.
  Έκδοση: (2013)
• Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.
  ανά: Green, J, κ.ά.
  Έκδοση: (2013)
• Assessing the safety of sitagliptin in older participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
  ανά: Bethel, M, κ.ά.
  Έκδοση: (2017)
• Pancreatic safety of sitagliptin in the TECOS Study.
  ανά: Buse, J, κ.ά.
  Έκδοση: (2016)
• Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS Trial.
  ανά: Josse, R, κ.ά.
  Έκδοση: (2016)